Mauna Kea Technologies: Pancreatic Cancer Awareness Month: Understanding Cellvizio® in Clinical Practice

PARIS & BOSTON–(BUSINESS WIRE)–Regulatory News: Dear Shareholders and Investors, November is Pancreatic Cancer Awareness Month. It highlights a major public health challenge that concerns us all: with the widespread use of cross-sectional imaging (CT and MRI), pancreatic cyst lesions are now detected by chance in 3% to 10% of adults. For both physicians and patients, the critical challenge is to reliably distinguish benign cysts—to avoid unnecessary major surgery—from cysts that may progress

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.